163 related articles for article (PubMed ID: 728322)
1. The features of hepatic enzyme induction with glutethimide in man.
Jackson L; Homeida M; Roberts CJ
Br J Clin Pharmacol; 1978 Dec; 6(6):525-8. PubMed ID: 728322
[TBL] [Abstract][Full Text] [Related]
2. Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man.
Hunter J; Burnham WR; Chasseaud LF; Down W
Biochem Pharmacol; 1974 Sep; 23(17):2480-3. PubMed ID: 4429583
[No Abstract] [Full Text] [Related]
3. Enzyme induction and serum and lipoprotein lipids: a study of glutethimide in normal subjects.
Bolton CH; Jackson L; Roberts CJ; Hartog M
Clin Sci (Lond); 1980 May; 58(5):419-21. PubMed ID: 7389270
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
Traeger A; Horváth T; Rechenbach C; Jávor T
Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
[TBL] [Abstract][Full Text] [Related]
5. Drug induction of hepatic enzymes in the elderly.
Pearson MW; Roberts CJ
Age Ageing; 1984 Sep; 13(5):313-6. PubMed ID: 6496244
[TBL] [Abstract][Full Text] [Related]
6. Urinary D-glucaric acid excretion during rifampicin/isoniazid and anticonvulsant enzyme induction.
Perry W; Stamp TC
Clin Pharmacol Ther; 1984 May; 35(5):710-5. PubMed ID: 6143635
[TBL] [Abstract][Full Text] [Related]
7. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
Breimer DD; Zilly W; Richter E
Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
[TBL] [Abstract][Full Text] [Related]
8. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
Roberts CJ; Jackson L; Halliwell M; Branch RA
Br J Clin Pharmacol; 1976 Oct; 3(5):907-13. PubMed ID: 973986
[TBL] [Abstract][Full Text] [Related]
9. Enzyme induction and renal function in man.
Ohnhaus EE; Martin J; Kinser J; Colombo JP
Br J Clin Pharmacol; 1977 Feb; 4(1):33-7. PubMed ID: 843422
[TBL] [Abstract][Full Text] [Related]
10. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
Gachályi B; Tornyossy M; Vas A; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
[TBL] [Abstract][Full Text] [Related]
11. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
Perry W; Jenkins MV
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
Buchanan N; Eyberg C; Davis MD
Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967
[TBL] [Abstract][Full Text] [Related]
13. m-Trifluoromethyl-alpha-ethylbenzhydrol: a new enzyme inducer.
Gachályi B; Káldor A; Szeberényi S
Eur J Clin Pharmacol; 1978 Jun; 13(4):299-302. PubMed ID: 668788
[TBL] [Abstract][Full Text] [Related]
14. Glutethimide and enzyme induction.
Roberts C; Jackson L; Homeida M
Br Med J; 1976 Nov; 2(6046):1256-7. PubMed ID: 990872
[No Abstract] [Full Text] [Related]
15. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
16. Liver blood flow and enzyme induction in man.
Ohnhaus EE; Noelpp UB; Ramos MR
Hepatogastroenterology; 1985 Apr; 32(2):61-4. PubMed ID: 4007764
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
Perucca E; Hedges A; Makki KA; Richens A
Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261
[TBL] [Abstract][Full Text] [Related]
18. The effect of enzyme induction on diazepam metabolism in man.
Ohnhaus EE; Park BK; Colombo JP; Heizmann P
Br J Clin Pharmacol; 1979 Dec; 8(6):557-63. PubMed ID: 42427
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of hepatic drug metabolism by glutethimide in patients with liver disease.
Farrell GC; Cooksley WG; Powell LW
Eur J Clin Pharmacol; 1979 Sep; 16(2):113-7. PubMed ID: 499307
[TBL] [Abstract][Full Text] [Related]
20. Human tolerance of flumecinol (Zixoryn, RGH-3332), its regime and dosage in healthy volunteers.
Vezekenyi Z; Ferenci J; Radnai B; Horvath T; Past T; Nagy L; Jávor T
Int J Clin Pharmacol Res; 1983; 3(2):77-88. PubMed ID: 6679516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
